(Q63302052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Primary breast cancer in elderly women: biological profile and relation with clinical outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Gabriele Martelli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Danila Coradini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Silvia Veneroni

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

313-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

Cancer epidemiology in the elderly

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Tumor characteristics and clinical outcome of elderly women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Breast cancer care in old age: what we know, don't know, and do.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2802%2900144-0

7 January 2021

10.1016/S1040-8428(02)00144-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12633842%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference